Christopher D. Hillyer is a practicing physician-scientist board-certified in internal medicine, hematology, medical oncology, and transfusion medicine who founded NYBC Ventures from inside a major blood-center organization he grew into a $600M+-per-year enterprise serving nearly 45 countries, all while looking for startups that offer both a humanitarian and a financial return. Beyond investing, he has led major blood and transfusion institutions like AABB and the National Blood Foundation, co-founded companies including 3Ti and HemeXcel, published over 200 articles and edited 13 textbooks, and earned two Tiffany Awards from the American Red Cross for PEPFAR-related work in Africa.